IFNG and interstitial lung disease: Therefore, clinicians should be aware of the risk of complications from M. tuberculosis infections and regularly perform chest X-rays, sputum AFB tests, and IFN-γ release assays on anti-PL-7 antibody-positive ILD patients undergoing intense immunosuppressive treatment.